Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis
1 Correction to: CNS Drugs https://doi.org/10.1007/s40263-018-0553-1
An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1 on 24 August 2018. An error was subsequently identified in the article, and the following correction should be noted:
Author listing: The name of the second author, which previously read:
The original article has been corrected.